 |
QSUM's MammoGown
|
Chest radiation to treat childhood cancer increases patients' risk of breast cancer. Patients who received chest radiation for Wilms tumor, a rare childhood cancer, face an increased risk of developing breast cancer later in life due to their radiation exposure.
Improving breast cancer chemo by testing patient's tumors in a dish. A technique that monitors the response of 3D chunks of a patient's tumor has been developed to determine how effective different anti-cancer drugs will be before starting chemotherapy.
Genomic Sequencing Helps Target Breast Cancer Screening. A prediction model employing known breast cancer-related genetic variants could help select women most likely to benefit from breast cancer screening.
FDA Approves Expanded Use of Navidea's Lymphoseek for Lymphatic Mapping in Solid Tumors. Lymphatic mapping using a handheld gamma counter to locate lymph nodes draining a primary tumor site in patients with solid tumors for which this procedure is a component of intraoperative management; and Guiding sentinel lymph node biopsy (SLNB) using a handheld gamma counter in patients with clinically node negative squamous cell carcinoma (SCC) of the oral cavity, breast cancer or melanoma.
Better breast cancer screening: How innovation is replacing the one-size-fits-all approach. The future of breast cancer care, however, lies in even earlier detection and individually tailored diagnosis and treatment, and imaging manufacturers are developing technologies that make these possible.
Biomarkers uPA/PAI-1 in breast cancer: Benefit, harm of test unclear. It remains unclear for patients with an intermediate risk of recurrence which benefit or harm a treatment strategy based on this test may have for them.
Selenium effective treatment against breast cancer. Selenium, when attached to a monoclonal antibody presently used to treat breast cancer, has shown greater success in destroying cancer cells in a patient who has developed resistance to the chemotherapy.
A Youthful Approach to Breast Cancer Prevention. Study after study shows that the earlier in life healthy behaviors take hold, the greater the opportunity to lower the risk of diseases like heart disease and cancer -- and to extend life.
IntelePACS Facilitates the Expansion of One of the Fastest-Growing Radiology Providers in the U.S. A rapidly-growing organization, SimonMed is particularly adept at finding areas of opportunity in the market where individual- or multiple-center operations can be easily integrated into their larger network, providing economies of scale and cost efficiencies that wouldn't be available to smaller organizations. Playing a key role in SimonMed's continued expansion has been Intelerad's IntelePACS solution.
Carestream Demos New Digital Breast Tomosynthesis Capabilities. Carestream's Vue Mammo Workstation features an enhanced digital breast tomosynthesis (DBT) module including a DBT image map, improved workflow settings, and the display of DICOM-compliant 2-D synthetic views, which are calculated from the 3-D dataset.
Pros and Cons of Universal Screening of Women for BRCA Mutations. A recent study that looked to identify women mutation carriers with no family or personal history of breast or ovarian cancer.[3] This study started by screening healthy Ashkenazi Jewish men, a population in which BRCA mutations are known to be prevalent. Women found to be mutation carriers, strictly because they were related to these male carriers, had a 60% risk for breast and/or ovarian cancer by age 60, confirming that regardless of history, harboring a mutation places women at high risk.
Skipping Axillary Node Disection in Some Early Breast Cancers Is Criticized. The Z0011 investigators reported previously that overall survival was highly similar at 6 years among early-stage breast cancer patients with minimal disease in their axilla who were treated with either sentinel lymph node biopsy alone or completion axillary lymph node dissection (ALND).
Decoding Breast Cancer Risk: BRCA and Beyond. BRCA gene mutations put women at high risk for breast and ovarian cancer, but who should be screened for these mutations? 15 Worst Things You Can Say to Someone Battling Breast Cancer. People don't mean to be insensitive, the news just scares them, and they don't know the right thing to say.
Breast Ca: The Price of a 'Cure'. Managing bone health in breast cancer is the awareness that common breast cancer treatments cause bone loss by decreasing estrogen, and women should ask whether they are at risk for bone loss and subsequent osteoporosis.
|